Neoadjuvant chemotherapy is the best option for some patients with ovarian cancer, according to a recent report. While some women with ovarian cancer will benefit most from primary cytoreductive ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of ...

Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...

Ovarian cancer mortality has declined, but racial and age disparities persist, with non-Hispanic White patients having the highest AAMRs. Non-Hispanic Asian or Pacific Islander populations show the ...

At 27, Nadia Le Tiec was in the prime of her life, full of energy and ambition. She had excellent grades and a thriving career. She would wake up at 6 a.m. every morning and stick to an enviable ...